Unveiling the Real-World Hurdles in DKA Prevention

Diabetic Ketoacidosis (DKA), a life-threatening complication primarily affecting individuals with type 1 diabetes, arises when the body produces high levels of blood acids called ketones due to insufficient insulin. This condition occurs when the body breaks down fat and muscle for energy instead of glucose, leading to dangerous acidity in the blood. Symptoms include excessive thirst, frequent urination, nausea, abdominal pain, rapid breathing, and confusion, often requiring immediate hospital intervention. In Canada, DKA results in thousands of hospitalizations annually, straining healthcare resources and impacting quality of life for patients.

Recent research from Diabetes Action Canada (DAC), a pan-Canadian patient-oriented research network funded by the Canadian Institutes of Health Research (CIHR), sheds light on why prevention remains elusive despite available knowledge. Led by Dr. Bruce A. Perkins, a professor at the University of Toronto's Temerty Faculty of Medicine and affiliated with Sinai Health, the study published in the Canadian Journal of Diabetes in November 2025 identifies specific patient-level barriers using implementation science frameworks.

This work underscores the need for tailored educational tools and technology integration, positioning Canadian universities like the University of Toronto at the forefront of advancing diabetes care through rigorous, collaborative research.

Inside the Diabetes Action Canada Study Design

The study employed a qualitative approach, conducting three sequential virtual focus groups with 22 diverse participants: nine adults living with type 1 diabetes, one caregiver, and 12 healthcare providers from across Canada. Recruitment leveraged DAC's Connect1d registry (connect1d.ca), ensuring voices with lived experience were central.

Guided by the Action, Actor, Context, Target, Time (AACTT) framework, researchers targeted three critical behaviors: ketone testing, acting on ketone results (e.g., insulin adjustment), and seeking emergency care. Data analysis used deductive coding via the Theoretical Domains Framework (TDF), followed by thematic synthesis and member checking for validity. This rigorous methodology highlights academic excellence from institutions like University of Toronto and University of British Columbia, contributors to the author team including Natasha J. Verhoeff and Wajeeha Cheema, a patient partner.

Primary Barriers to Effective DKA Prevention

Participants revealed multifaceted barriers, categorized into knowledge gaps, practical hurdles, psychological factors, and systemic issues. Understanding these is crucial for developing targeted interventions.

• Lack of Ketone Knowledge: Many couldn't distinguish ketones from high blood glucose or grasp clinical risks, leading to delayed testing.
• Memory and Supply Overload: Overwhelmed by daily diabetes management, retaining sick-day protocols was challenging; ketone strips were costly or inaccessible.
• Mental Health and Identity Struggles: Diabetes burnout, denial of illness ('not sick enough'), and resistance to new routines hindered action.
• Healthcare System Distrust: Past stigma, judgment, or dismissal in emergency settings deterred help-seeking.

These insights from DAC research emphasize that prevention fails not due to willful neglect but systemic and behavioral complexities.Explore research positions advancing diabetes studies at Canadian universities.

Real-World Stories: Patients' Lived Experiences

Focus group quotes paint vivid pictures. One participant shared, "I know I should test ketones when sick, but with everything else—bolusing, counting carbs—it's one step too many." Another described emergency room fears: "They treat you like you're non-compliant, not ill." These narratives, drawn from coast-to-coast Canadians, reveal emotional tolls like anxiety and isolation.

In Canada, where approximately 250,000 live with type 1 diabetes, such episodes contribute to 5-7% annual DKA occurrences per patient, far too high amid pandemic increases. Case studies from Ontario and British Columbia underscore regional variations, like supply access in rural areas.

Healthcare Providers' Insights on Challenges

Clinicians echoed patient struggles, noting inconsistent education delivery and time constraints in appointments. "Patients get overwhelmed by info dumps," one said. Providers advocated for simplified tools but highlighted gaps in training on behavioral change techniques. This multi-perspective view strengthens the study's credibility, involving experts from UBC and U Toronto.

Enablers Paving the Way Forward

Amid barriers, enablers emerged: clinician reminders, app alerts, peer support groups, and plain-language visuals. Community forums via Connect1d foster shared learning, reducing isolation. DAC's approach prioritizes these for scalable change.Learn more about DAC's T1D innovations.

Emerging Tech: Continuous Ketone Monitoring Revolution

Technologies like continuous glucose monitors (CGMs) have transformed management; now, continuous ketone monitoring (CKM) promises alerts for rising ketones. Breakthrough T1D Canada funds CKM development, with international guidelines published December 2025. DAC research positions CKM implementation by addressing education barriers first. University-led trials at U Toronto could integrate CKM into a single sensor with CGM.

Developing Actionable Solutions: The Infographic Initiative

DAC plans to co-create a visual DKA prevention infographic with patient partners like Wajeeha Cheema, testing for usability. This tool will simplify steps: test ketones if glucose >14 mmol/L or ill; act on moderate/high (extra insulin, carbs/hydration); seek care if persistent. Timeline: prototype Spring 2026.

Broader Implications for Canada's Diabetes Landscape

With diabetes prevalence at 9.4% (2023-24), rising to 14 million by 2034 including prediabetes, DKA prevention aligns with national strategies.Discover diabetes-related academic opportunities in Canada This research informs policy, urging subsidized strips and HCP training. Universities play key roles, training future endocrinologists.

Actionable Steps for Patients, Providers, and Policymakers

• Patients: Join Connect1d, use apps for reminders, stock strips.
• Providers: Adopt simplified education, promote CKM trials.
• Policymakers: Fund CKM, reduce strip costs.

For career growth in this field, explore tips on academic CVs or professor reviews. DAC exemplifies patient-oriented research driving impact.

In conclusion, Diabetes Action Canada research illuminates paths to slash DKA rates, blending academic rigor with lived wisdom. Stay tuned for the infographic and engage via higher ed jobs in diabetes research.

Photo by chris robert on Unsplash